A new study shows a link between patient survival and changes in tumor cell mass after glioblastoma treatment. — ScienceDaily
Researchers at MIT and Dana-Farber Cancer Institute have developed a new way to determine whether individual patients will respond to a specific cancer drug or not. This kind of test…
